Ovid Therapeutics Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
Ovid Therapeutics (OVID) IPO Opens 7% Lower
May 5, 2017 10:43 AM EDTToday's IPO for Ovid Therapeutics (NASDAQ: OVID) opened for trading at $14 after pricing 5,000,000 shares of its common stock at a public offering price of $15.00 per share.
In addition, Ovid Therapeutics has granted the underwriters a 30-day option to purchase up to 750,000... More
